Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zealand Pharma (ZLDPF)
OTHER OTC:ZLDPF
Holding ZLDPF?
Track your performance easily
ZLDPF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$31.81 - $140.28
Previous Close$135
Volume467.00
Average Volume (3M)2.07K
Market Cap
$9.52B
Enterprise Value$9.42B
Total Cash (Recent Filing)kr1.18B
Total Debt (Recent Filing)kr443.47M
Price to Earnings (P/E)―
Beta0.15
Next Earnings
Aug 15, 2024EPS Estimate
-$0.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.81
Shares Outstanding62,615,203
10 Day Avg. Volume2,752
30 Day Avg. Volume2,073
Standard Deviation0.15
R-Squared0.10
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)78.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$139.40Price Target Upside2.86% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Zealand Pharma News
PremiumCompany Announcements
Zealand Pharma’s 2024 Progress and Financial Results
Ownership Overview
0.00%
Insiders
11.77% Mutual Funds
4.89% Other Institutional Investors
83.34% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ZLDPF FAQ
What was Zealand Pharma’s price range in the past 12 months?
Zealand Pharma lowest stock price was $31.81 and its highest was $140.28 in the past 12 months.
What is Zealand Pharma’s market cap?
Currently, no data Available
When is Zealand Pharma’s upcoming earnings report date?
Zealand Pharma’s upcoming earnings report date is Aug 15, 2024 which is 127 days ago.
How were Zealand Pharma’s earnings last quarter?
Zealand Pharma released its earnings results on May 16, 2024. The company reported -$0.541 earnings per share for the quarter, beating the consensus estimate of -$0.567 by $0.026.
Is Zealand Pharma overvalued?
According to Wall Street analysts Zealand Pharma’s price is currently Undervalued.
Does Zealand Pharma pay dividends?
Zealand Pharma does not currently pay dividends.
What is Zealand Pharma’s EPS estimate?
Zealand Pharma’s EPS estimate is -$0.48.
How many shares outstanding does Zealand Pharma have?
Zealand Pharma has 71,000,760 shares outstanding.
What happened to Zealand Pharma’s price movement after its last earnings report?
Zealand Pharma reported an EPS of -$0.541 in its last earnings report, beating expectations of -$0.567. Following the earnings report the stock price went down -4.355%.
Which hedge fund is a major shareholder of Zealand Pharma?
Currently, no hedge funds are holding shares in ZLDPF
---
Zealand Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$139.40 (2.86% Upside)
$139.40 (2.86% Upside)
Blogger Sentiment
Bullish
ZLDPF Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 4.7%
Last 30 Days ▲ 4.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
289.77%
12-Months-Change
Fundamentals
Return on Equity
-42.16%
Trailing 12-Months
Asset Growth
165.64%
Trailing 12-Months
Company Description
Zealand Pharma
Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark.
---
ZLDPF Company Deck
---
ZLDPF Earnings Call
Q1 2024
0:00 / 0:00
---
ZLDPF Stock 12 Month Forecast
Average Price Target
$139.40
▲(2.86% Upside)
Technical Analysis
Best Analysts Covering ZLDPF
1 Year
1 Year Success Rate
4/4 ratings generated profit
1 Year Average Return
+96.33%
reiterated a buy rating 6 months ago
Copying Rajan Sharma's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +96.33% per trade.
---